ARCHIVES

New Drugs Improve Outlook For Bone Marrow Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 3 | March 31, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Would Fund 152 More Grants Under President’s Budget

February 17, 1995

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

March 12, 1976

Lilly Begins Phase III Trial Of Alimta In Extensive SCLC

October 27, 2006

RAC Grumbles, Gives Healy Guidelines For Compassionate Use Of Gene Therapy

January 22, 1993

NCI Cooperative Group Clinical Trials Listed

April 24, 2009

New Therapeutic Approaches Improve Palliative Care

June 27, 2003